+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Anti Tumour Necrosis Factor"

Axial Spondyloarthritis (AxSpA) Market Report 2025 - Product Thumbnail Image

Axial Spondyloarthritis (AxSpA) Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Rheumatoid Arthritis Drugs Market Report 2025 - Product Thumbnail Image

Rheumatoid Arthritis Drugs Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Intratumoral Cancer Therapies Market Report 2025 - Product Thumbnail Image

Intratumoral Cancer Therapies Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Psoriasis Treatment - Global Strategic Business Report - Product Thumbnail Image

Psoriasis Treatment - Global Strategic Business Report

  • Report
  • March 2025
  • 193 Pages
  • Global
From
From
From
From
Etanercept - Biosimilar Insight, 2024 - Product Thumbnail Image

Etanercept - Biosimilar Insight, 2024

  • Report
  • August 2024
  • 60 Pages
  • Global
From
From
Acute Graft-Versus-Host Disease - Pipeline Insight, 2024 - Product Thumbnail Image

Acute Graft-Versus-Host Disease - Pipeline Insight, 2024

  • Drug Pipelines
  • June 2024
  • 80 Pages
  • Global
From
Ulcerative Colitis - Pipeline Insight, 2024 - Product Thumbnail Image

Ulcerative Colitis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 240 Pages
  • Global
From
Rheumatoid Arthritis - Pipeline Insight, 2024 - Product Thumbnail Image

Rheumatoid Arthritis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 250 Pages
  • Global
From
From
Mastocytosis - Pipeline Insight, 2024 - Product Thumbnail Image

Mastocytosis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Cryoprin-Associated Periodic Syndrome - Pipeline Insight, 2024 - Product Thumbnail Image

Cryoprin-Associated Periodic Syndrome - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 40 Pages
  • Global
From
From
Loading Indicator

The Anti Tumour Necrosis Factor (anti-TNF) market is a subset of the Immune Disorders Drugs market. Anti-TNF drugs are used to treat a variety of immune-mediated diseases, such as rheumatoid arthritis, psoriasis, Crohn's disease, and ulcerative colitis. These drugs work by blocking the action of TNF, a protein that is involved in inflammation and tissue destruction. Anti-TNF drugs are generally administered as injections or infusions, and are often used in combination with other medications. The anti-TNF market is highly competitive, with a number of companies offering products. These include AbbVie, Amgen, Janssen, Merck, Pfizer, and UCB. Each company has its own portfolio of anti-TNF drugs, and they are continually developing new products to meet the needs of patients. Show Less Read more